ACR logo

ACR AC Portal

Home Staging and Follow-up of Pancreatic Neuroendocrine Tumors
Variants
Scenario Scenario ID Procedure Adult RRL Peds RRL Appropriateness Category
Pancreatic neuroendocrine tumor, liver dominant disease, post treatment follow-up imaging 3199624
MRI abdomen and pelvis without and with IV contrast
0 mSv
O 		0 mSv [ped]
O 		Usually appropriate
CT abdomen and pelvis without and with IV contrast
10-30 mSv
☢☢☢☢ 		10-30 mSv [ped]
☢☢☢☢☢ 		Usually appropriate
CT chest abdomen pelvis with IV contrast
10-30 mSv
☢☢☢☢ 		3-10 mSv [ped]
☢☢☢☢ 		Usually appropriate
CT chest abdomen pelvis without and with IV contrast
10-30 mSv
☢☢☢☢ 		10-30 mSv [ped]
☢☢☢☢☢ 		Usually appropriate
MRI abdomen and pelvis without IV contrast
0 mSv
O 		0 mSv [ped]
O 		May be appropriate
(Disagreement)
MRI abdomen without and with IV contrast with MRCP
0 mSv
O 		0 mSv [ped]
O 		May be appropriate
(Disagreement)
MRI abdomen without IV contrast with MRCP
0 mSv
O 		0 mSv [ped]
O 		May be appropriate
(Disagreement)
CT abdomen and pelvis with IV contrast
1-10 mSv
☢☢☢ 		3-10 mSv [ped]
☢☢☢☢ 		May be appropriate
(Disagreement)
DOTATATE PET/CT skull base to mid-thigh
1-10 mSv
☢☢☢
May be appropriate
(Disagreement)
US abdomen endoscopic
0 mSv
O 		0 mSv [ped]
O 		Usually not appropriate
CT abdomen and pelvis without IV contrast
1-10 mSv
☢☢☢ 		3-10 mSv [ped]
☢☢☢☢ 		Usually not appropriate
CT chest abdomen pelvis without IV contrast
10-30 mSv
☢☢☢☢ 		3-10 mSv [ped]
☢☢☢☢ 		Usually not appropriate
FDG-PET/CT skull base to mid-thigh
10-30 mSv
☢☢☢☢ 		3-10 mSv [ped]
☢☢☢☢ 		Usually not appropriate
© 2025